Psychedelic drugs, also known as ‘magic mushrooms’, ‘trippy pills’ and ‘party favors’ are a class of hallucinogenic substances that cause profound alterations in perception when administered. However, many of these compounds also have important medical applications, especially for treating mental health conditions.

Some common examples of psychedelic drugs include LSD (lysergic acid diethylamide), psilocybin mushrooms, MDMA (ecstasy), DMT (dimethyltryptamine), ketamine and ibogaine. These drugs act by interacting with serotonin receptors in the brain to produce psychedelic experiences characterized by sensory distortions, emotional and cognitive shifts.

Rising Acceptance of Psychedelic Therapies

In recent years, there has been renewed interest from the scientific community in studying potential medical uses of psychedelics due to promising early research. Many clinical trials are now investigating whether microdosing or therapeutic dosing of psilocybin, MDMA and ketamine can help treat conditions like depression, PTSD, addiction and anxiety.

For example, studies have shown psilocybin therapy to be highly effective for reducing symptoms of treatment-resistant depression when administered alongside psychotherapy. MDMA is also being explored for helping with PTSD.

This resurgence in psychedelic research has helped to reduce stigma around therapeutic uses and increase acceptance among the medical community and general public. Several jurisdictions have also taken steps to decriminalize or reduce penalties associated with psychedelic substances.

Psychedelic Drugs - https://www.coherentmi.com/blog/psychedelic-drugs-is-undergoing-rapid-growth-and-acceptance-140